Cargando…

Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis

BACKGROUND: The prevalence of telomerase reverse transcriptase (TERT) promoter mutations (pTERTm) in non-small-cell lung cancer (NSCLC) have been investigated, but the results were inconsistent. In addition, several studies have analysed the role of pTERTm in the etiology of various types of cancers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ping, Cao, Jin-lin, Abuduwufuer, Abudumailamu, Wang, Lu-Ming, Yuan, Xiao-Shuai, Lv, Wang, Hu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723146/ https://www.ncbi.nlm.nih.gov/pubmed/26799744 http://dx.doi.org/10.1371/journal.pone.0146803

Ejemplares similares

Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76 108 Cases and 134 215 Controls
por: Cao, Jin-Lin, et al.
Publicado: (2015)

The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans
por: Zhang, Chong, et al.
Publicado: (2017)

The role of HIF-1α-VEGF pathway in bronchiolitis obliterans after lung transplantation
por: Xu, Haichao, et al.
Publicado: (2019)

The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2018)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017)

Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis
por: Shuai, Hui, et al.
Publicado: (2023)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
por: van Poppelen, Natasha M., et al.
Publicado: (2021)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

The Solo Play of TERT Promoter Mutations
por: Hafezi, François, et al.
Publicado: (2020)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
por: Park, Jun, et al.
Publicado: (2021)

Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
por: Hasanau, Tsimur, et al.
Publicado: (2022)

TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis
por: Wang, Yanbing, et al.
Publicado: (2022)

TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
por: Tang, Feng, et al.
Publicado: (2023)

Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
por: Wei, Tong, et al.
Publicado: (2023)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
por: Salgado, Catarina, et al.
Publicado: (2020)

TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
por: Liu, Tiantian, et al.
Publicado: (2023)

Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis
por: Tao, Lian-yuan, et al.
Publicado: (2016)

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
por: Blateau, Pauline, et al.
Publicado: (2020)

Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
por: Liu, Tiantian, et al.
Publicado: (2016)

Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015)

Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas
por: Mellai, Marta, et al.
Publicado: (2021)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
por: Hugdahl, Emilia, et al.
Publicado: (2018)

MPC-01 PROGNOSTIC ROLE OF TERT PROMOTER IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA
por: Arita, Hideyuki, et al.
Publicado: (2019)

TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases
por: Insilla, Andrea Cacciato, et al.
Publicado: (2018)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3r2j5dvvjsb1af1bcggpo6gp71